This paper describes the usage and the performance evaluation of the completeness index method in the ‘Surveillance of Rare Cancers in Europe project’ (RARECARE) for estimating rare cancer prevalence in Europe. The 15-year prevalence at 1st January 2003 for 255 cancers is obtained from a pool of 22 RARECARE cancer registries (CRs). Incidence and survival models are applied to the RARECARE database to estimate the parameters from which the completeness indices are calculated. Complete prevalence is obtained adjusting the observed 15-year prevalence by the completeness index, to account for those cancer survivors diagnosed before the CR activity started. Main factors influencing the performance of the completeness index method for rare cancer...
Purpose Rare cancers represent 22% of all tumors in Europe; however, the quality of the data of rare...
The burden of rare tumors in Europe is still unknown and no generally accepted definition of them ex...
The conventional definition for rare disease is based on prevalence. Because of differences in progn...
This paper describes the usage and the performance evaluation of the completeness index method in th...
Rare cancers epidemiology is better known compared to the other rare diseases. Thanks to the long hi...
IntroductionComparable indicators on complete cancer prevalence are increasingly needed in Europe to...
Purpose: Epidemiologic information on rare cancers is scarce. The project Surveillance of Rare Cance...
Purpose: Epidemiologic information on rare cancers is scarce. The project Surveillance of Rare Cance...
Background Rare cancers pose challenges for diagnosis, treatments, and clinical decision making. Inf...
Cancer prevalence is the proportion of individuals in a population who at some stage during their li...
Cancer prevalence is the proportion of individuals in a population who at some stage during their li...
Abstract The burden of rare tumors in Europe is still unknown and no generally accepted definition ...
Cancer prevalence is an important measure of the burden of the disease in a population and on the he...
Epidemiologic information on rare cancers is scarce. The project Surveillance of Rare Cancers in Eur...
The conventional definition for rare disease is based on prevalence. Because of differences in progn...
Purpose Rare cancers represent 22% of all tumors in Europe; however, the quality of the data of rare...
The burden of rare tumors in Europe is still unknown and no generally accepted definition of them ex...
The conventional definition for rare disease is based on prevalence. Because of differences in progn...
This paper describes the usage and the performance evaluation of the completeness index method in th...
Rare cancers epidemiology is better known compared to the other rare diseases. Thanks to the long hi...
IntroductionComparable indicators on complete cancer prevalence are increasingly needed in Europe to...
Purpose: Epidemiologic information on rare cancers is scarce. The project Surveillance of Rare Cance...
Purpose: Epidemiologic information on rare cancers is scarce. The project Surveillance of Rare Cance...
Background Rare cancers pose challenges for diagnosis, treatments, and clinical decision making. Inf...
Cancer prevalence is the proportion of individuals in a population who at some stage during their li...
Cancer prevalence is the proportion of individuals in a population who at some stage during their li...
Abstract The burden of rare tumors in Europe is still unknown and no generally accepted definition ...
Cancer prevalence is an important measure of the burden of the disease in a population and on the he...
Epidemiologic information on rare cancers is scarce. The project Surveillance of Rare Cancers in Eur...
The conventional definition for rare disease is based on prevalence. Because of differences in progn...
Purpose Rare cancers represent 22% of all tumors in Europe; however, the quality of the data of rare...
The burden of rare tumors in Europe is still unknown and no generally accepted definition of them ex...
The conventional definition for rare disease is based on prevalence. Because of differences in progn...